{"version":"1.0","type":"link","title":"Fruquintinib with programmed cell death - 1 inhibitors versus triflueridine - tipiracil - 102 with bevacizumab in late-line mCRC: A retrospective cohort study based on propensity score matching.","author_name":"Li RR 외","author_url":"https://prs-insight.online/author/Li%20RR","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/102772","thumbnail_width":1200,"thumbnail_height":630}